BISULFIM tablets , Sulfadiazine 125 mg/Trimethoprim 25 mg , 20 tablets

COMPOSITION
1 tablet contains:
Active substances:
Sulfadiazine …………………………………………………………………………..125 mg
Trimethoprim ………………………………………………………………………….25 mg
Excipients:
talc, magnesium stearate, stearic acid, microcrystalline cellulose,
lactose monohydrate, colloidal silicon dioxide.
INDICATIONS
The product is indicated in dogs and cats in the treatment of primary
and secondary bacterial infections caused by germs sensitive
to sulfadiazine and trimethoprim (respiratory, gastrointestinal
infections, urogenital, postoperative infections, oral cavity infections,
ophthalmic and auricular infections, skin infections, sepsis).
CONTRAINDICATIONS
Do not administer to animals with severe kidney and liver diseases.
Do not administer to animals known to be hypersensitive to the
active substances or any of the excipients.
ADVERSE REACTIONS
Sometimes skin rashes (hives), gastric irritation (anorexia,
vomiting), polyarthritis, keratitis, allergic reactions: itching,
erythema, dermatitis, alopecia, conjunctivitis may occur.
TARGET SPECIES
Dogs, cats.
ADMINISTRATION
BISULFIM tablets are administered orally, as such, or incorporated
into the food, after crushing the tablet. Dogs: The recommended
dose is 15 – 30 mg a.s./ kg b.w./day, for 5-7 days. Administer 1-2
tablets/10 kg of weight body/day. Cats: The recommended dose is
30 mg a.s./kg b.w./day, for 5 – 7 days. Administer 1 tablet/5 kg
body weight/day. In case of severe infections, the treatment can be
extended up to 5-6 weeks.
RECOMMENDATIONS FOR PROPER ADMINISTRATION
To ensure correct dosage, body weight must determined as precisely
as possible.
USE DURING PREGNANCY, LACTATION
Do not administer to pregnant and lactating females.
INTERACTIONS WITH OTHER MEDICINAL PRODUCTS OR OTHER
FORMS OF INTERACTION
The product is incompatible with procaine benzylpenicillin, procaine
and similar local anesthetics.
DOSAGE
Overdose symptoms may include: nausea, vomiting, diarrhea,
confusion, drowsiness. In carnivores, the administration of large
amounts of sulfonamides may give rise to nervous phenomena,
especially in youth.
WITHDRAWAL PERIOD
Not applicable.
STORAGE
Store at a temperature below 25°C, in the original packaging,
protected from direct light and moisture.

PRESENTATION
Boxes of 2 blisters x 10 tablets.